Share. Connect. Create. Grow. · Socialiya
Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline

Gilead has struck a deal to buy Tubulis for $3.15 billion upfront, securing an ADC candidate that is...

BUSINESS NEWS April 07, 2026

Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline

Gilead has struck a deal to buy Tubulis for $3.15 billion upfront, securing an ADC candidate that is racing toward pivotal trials.

33 views 0 likes 0 comments
Share:
Gilead has struck a deal to buy Tubulis for $3.15 billion upfront, securing an ADC candidate that is racing toward pivotal trials.

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya